Search Results
Jun 25, 2025, 09:00 ET SK chemicals Signs Exclusive Partnership Agreement with Austria's Durmont to Supply Sustainable Materials to Global Automotive Brands
technology, SKYPET CR maintains a quality level close to that of virgin petroleum-based products even after repeated recycling—unlike conventional recycling methods—making it an ideal material for establishing a closed-loop system. By applying SKYPET CR to automotive
More news about: SK chemicals
Jun 25, 2025, 03:00 ET SK chemicals unterzeichnet exklusive Partnerschaft mit dem österreichischen Unternehmen Durmont zur Belieferung globaler Automobilmarken mit nachhaltigen Materialien
Vereinbarung liefert SK chemicals Durmont das recycelte PET SKYPET CR: 100 % aus recyceltem Material, ISCC PLUS‑zertifiziert und vollständig recycelbar. Ziel ist die breite Markteinführung dieser nachhaltigen Materiallösungen. SKYPET CR fußt auf SK chemicals' chemischer Recyclingtechnologie
More news about: SK chemicals
Jun 25, 2025, 03:00 ET SK chemicals Signs Exclusive Partnership Agreement with Austria's Durmont to Supply Sustainable Materials to Global Automotive Brands
recycled PET, SKYPET CR, which provides a material with 100% recycled content, certified by ISCC PLUS (International Sustainability and Carbon Certification PLUS), and a fully recyclable product. The joint aim is a wide market adoption of such sustainable material solutions. SKYPET CR, making use of SK
More news about: SK chemicals
Jun 25, 2025, 03:00 ET SK chemicals se asocia con Durmont para suministrar materiales sostenibles a marcas automotrices globales
químicamente (CR) diferenciada de SK chemicals, cumpliendo con los requisitos de prueba y estándares de calidad automotriz. El acuerdo exclusivo acelerará el suministro y la expansión en el mercado. Según el acuerdo, SK chemicals suministrará a Durmont su PET reciclado SKYPET CR, con un
More news about: SK chemicals
Jun 25, 2025, 03:00 ET SK chemicals signe un accord de partenariat exclusif avec Durmont (Autriche) pour fournir des matériaux durables à des marques automobiles mondiales
Durmont son PET recyclé SKYPET CR : un matériau constitué à 100 % de contenu recyclé, certifié ISCC PLUS, et entièrement recyclable. L'objectif commun est de favoriser une adoption généralisée de cette solution durable sur le marché. SKYPET CR, fruit de la technologie de
More news about: SK chemicals
Jun 24, 2025, 12:08 ET Ovarian Cancer Drugs Market Size expected to reach US$ 4.23 billion by 2031 | The Insight Partners
These inhibitors offer long-term efficacy and can enhance progression-free survival (PFS) in newly diagnosed patients who achieve a complete response (CR) after the first, second, or third rounds of platinum-based chemotherapy.Rising Demand for Precision Medicine and Targeted
More news about: The Insight Partners
Jun 24, 2025, 08:00 ET TuHURA Biosciences Initiates Its Phase 3 Accelerated Approval Trial of IFx-2.0 as an Adjunctive Therapy to Keytruda® (pembrolizumab) in First Line Treatment for Advanced or Metastatic Merkel Cell Carcinoma
administration of IFx-2.0 for up to three doses followed by rechallenge with anti-PD(L)-1 therapy. Results demonstrated an overall response rate of 63% (2 CR, 5 PR) with two responses lasting 23 and 33 months and five ongoing responses (6, 11, 13, 19 and 23 months) as of the last follow-up. "The initiation
More news about: TuHURA Biosciences, Inc.
Jun 24, 2025, 06:30 ET Nuvalent Announces Positive Pivotal Data from ARROS-1 Clinical Trial of Zidesamtinib for TKI Pre-treated Patients with Advanced ROS1-positive NSCLC
In patients that had measurable CNS lesions by BICR at baseline (n = 56), the IC-ORR was 48% with 20% (11/56) intracranial complete responses (CR) and 2 unconfirmed partial responses (PR), and IC-DOR ≥ 12 months of 71% (95% CI: 46, 87). In patients that had only received
More news about: Nuvalent, Inc.
Jun 23, 2025, 11:30 ET Actinium Highlights Expanded Data Set for ATNM-400 in Prostate Cancer Demonstrating Superior Efficacy to Enzalutamide and Ability to Overcome Resistance to ARPI Therapy and PSMA-Ac-225/Lu-177 Labelled Radiotherapy at the Society of Nuclear Medicine & Molecular Imaging Annual Meeting
relapsed and refractory acute myeloid leukemia (r/r AML) patients in combination with the chemotherapy CLAG-M including high rates of Complete Remissions (CR) and measurable residual disease (MRD) negativity leading to improved survival outcomes and is being advanced to a pivotal Phase 2/3 trial. In addition,
More news about: Actinium Pharmaceuticals, Inc.
Jun 20, 2025, 15:16 ET OnTime Networks Introduces Machete Router: A NIAP-Certified Tactical Routing Solution for Military and Aerospace Applications
and Virtual Options Machete is offered as both: A rugged embedded router, complementing OnTime Networks' CR-4000, CR-6000, and CR-7000 platforms A virtual appliance enabling compact, low-power, cost-effective deployments for less demanding environmentsAdvanced
More news about: OnTime Networks
Jun 20, 2025, 14:50 ET Customers Can Now Buy a Used Honda CR-V in Raleigh, North Carolina
this SUV as stylish as it is functional. The CR-V's four-wheel independent suspension and traction control system provide a stable ride whether navigating city traffic or heading out for a weekend getaway. Anyone interested in exploring a used Honda CR-V can stop by Auction Direct USA
More news about: Auction Direct USA
Jun 20, 2025, 08:30 ET TELUS Announces Cash Tender Offers for Eight Series of Debt Securities
+160 4.75% Senior Notes, Series CR due January, 2045 C$400
More news about: TELUS Corporation
Jun 19, 2025, 09:03 ET CR Fitness Holdings Launches One-Day Cyber Sale at Crunch Palm Harbor, FL
Arizona. About CR Fitness Holdings, LLCCR Fitness Holdings, LLC is the leading franchisee of Crunch Fitness, and led by a management team with over 150 years of combined experience in the fitness industry. CR Fitness is on track to operate 100 locations nationwide
More news about: CR Fitness Holdings, LLC.
Jun 18, 2025, 21:05 ET ShawKwei & Partners Completes Acquisition and Delisting of PEC Ltd
www.peceng.com for more information on PEC. Liberty Energy currently has two other wholly owned subsidiaries with CR3 Group ("CR3"), a leading energy engineering solutions leader, and ZymeFlow LLC ("ZymeFlow"), an innovator in chemical decontamination technologies. This PEC
More news about: ShawKwei & Partners
Jun 17, 2025, 17:05 ET LAZYDAYS COMPLETES LIQUIDITY ENHANCING TRANSACTIONS
support as we work to achieve these objectives." Stoel Rives LLP served as legal counsel, and Miller Buckfire, a Stifel Company, and CR3 Partners served as financial advisor to Lazydays and its Board of Directors in connection with these transactions. For further
More news about: Lazydays RV
Jun 17, 2025, 11:05 ET Steele Honda Welcomes 2026 Honda Models to Its New Vehicle Inventory
Popular models from the 2026 lineup that are now available include the Honda Passport, CR-V and HR-V. All bring enhanced performance and safety features. The 2026 Honda CR-V offers a 190-horsepower turbocharged engine, a standard Real Time AWD system and hybrid trims that push efficiency
More news about: Steele Honda
Jun 17, 2025, 09:00 ET Boom de Crystal Lagoons en Latinoamérica: Nuevas inauguraciones y proyectos firmados marcan un momento histórico para la multinacional
https://mma.prnewswire.com/media/2711987/Kristal_Malls_Render_Diurno_Nuevos_Volumenes_Post_Noviembre_2024_CR_NEW__2.jpg
More news about: Crystal Lagoons
Jun 17, 2025, 08:30 ET Honda Unveils New "Last Mile" Business Solution: Fastport, a Fleet-as-a-Service Company, Offering the Fastport eQuad Prototype
global parts. Since opening in 2016, the PMC has been responsible for production of the Acura NSX supercar, multiple Acura PMC Edition vehicles, and the CR-V e:FCEV fuel cell electric vehicle, as well as Honda Performance Development race cars. This makes the PMC and its expert production technicians uniquely
More news about: Honda
Jun 16, 2025, 10:48 ET Alliance Resource Partners, L.P. Announces 2025 Scholarship Recipients
graduate of North High School in Evansville, Indiana; daughter of John Hedges, employed by CR Services, LLC. Hyatt Kelley, graduate of Webster County High School in Dixon, Kentucky;
More news about: Alliance Resource Partners, L.P.
Jun 16, 2025, 09:00 ET AbelZeta Announces Promising Long-Term Outcomes for C-CAR039, a Novel CD19/CD20 Bi-Specific CAR-T Therapy, in Patients with R/R B NHL at EHA 2025
Key Findings: The overall response rate (ORR) and complete response (CR) rate were 91.5% and 85.1%, respectively for all patientsAmong the 43 LBCL pts, ORR and CR were 90.7% and 86.0%, respectivelyWith a median follow-up of 45.5 months (range, 3.1–62.8),
More news about: AbelZeta Pharma, Inc.
Jun 16, 2025, 09:00 ET AbbVie Provides Update on VERONA Trial for Newly Diagnosed Higher-Risk Myelodysplastic Syndromes
The primary outcome measure is overall survival (OS). Key secondary outcome measures include modified overall response (mOR) and complete remission (CR). More information can be found
More news about: AbbVie
Jun 16, 2025, 07:15 ET ADC Therapeutics Announces Updated ZYNLONTA® Investigator-Initiated Trial Data in R/R Marginal Zone Lymphoma Presented at 18th International Conference on Malignant Lymphoma (ICML)
rate (ORR) of 84.6% (22/26); complete response (CR) rate of 69.2% (18/26)Among POD24 patients assessed for response, a CR rate of 61.5% (8/13) was observedCR was maintained in 17 of 18 CR patients who achieved CR, with longest duration of CR of 27 months from start of treatmentProgression-free
More news about: ADC Therapeutics SA
Jun 15, 2025, 10:17 ET INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of UroGen
the briefing document, the FDA stated: "[g]iven that [the ENVISION trial] lacked a concurrent control arm, the primary endpoints of complete response (CR) and duration of response (DOR) are difficult to interpret." The FDA also said it had "recommended a randomized trial design to the Applicant several
More news about: Faruqi & Faruqi, LLP
Jun 15, 2025, 03:15 ET Investigational combination of first-in-class bispecifics TALVEY® and TECVAYLI® shows deep and durable responses in heavily pretreated multiple myeloma patients with extramedullary disease
TECVAYLI®, providing the option for a reduced dosing frequency of 1.5 mg/kg every two weeks (Q2W) in patients who have achieved a complete response (CR) or better for a minimum of six months. TECVAYLI® is a first-in-class, bispecific T-cell engager antibody therapy that uses innovative science
More news about: Johnson & Johnson
Jun 13, 2025, 10:44 ET Prior to FIFA Club World Cup Kickoff, FC Mother and Omya Launch Landmark Joint Venture to Fund "Life Years" as Part of World Cup of Healing Legacy Project
Mexico Over the past 3 months, FC Mother has enrolled more than 210 expectant mothers in its program, which is now live with participants from CR Flamengo in Brazil, from San Diego FC in the US, and from Club Tigres in Mexico.
More news about: FC Mother